Skip to main content
On Demand

Anticipating and Navigating Legal Risks in International Transactions


Average Rating:
Not yet rated
Categories:
International Drug Policy |  International Law
Faculty:
Marie Sanchez |  Eric P. Berlin |  Sherri Altshuler |  Paul-Michael Keichel |  Mr. Ohad Kiperstok
Duration:
1 Hour 01 Minutes
Format:
Audio and Video
SKU:
INCBA091624interOD
License:
Access for 6 month(s) after purchase.



Description

Anticipating and Navigating Legal Risks in International Transactions | Get practical insight on the key challenges cannabis and hemp operators are likely to face when engaging in international activities and expansion.

Credits


General

This program is eligible for 1 hours of General CLE credit in 60-minute states, and  hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules. 

INCBA webinars are generally eligible for credit in the following states: AR, AL, CA, CO, GA, HI, IL, NJ, NM, NY, ND, PA, TX, VT. Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.

The on-demand version of this webinar is eligible for credit in the following states: AR, AL, CA, CO, GA, HI, IL, NJ, NM, NY, ND, PA, TX, VT. Additional states may be available for credit upon self-application by attendees.

(Default credit disclaimer updated 02.08.2024)


For current accreditation status, please select your jurisdiction below.



Handouts

Faculty

Marie Sanchez's Profile

Marie Sanchez Related Seminars and Products

Lawyer & Founder

Nooa Avocats


Marie Sanchez is a lawyer at the Bars of Paris and Quebec. After beginning her career in Singapore with a large pharmaceutical group, she worked for nearly 10 years in renowned international law firms before founding NOOA Avocats.

A specialist in regulatory and contractual aspects related to life sciences, she has also developed expertise in the field of therapeutic cannabis and well-being hemp. She regularly intervenes in the context of training courses as well as in conferences, in France and abroad.

She holds a Master II Professional in Health Industry Law from the University of Montpellier I as well as an ESSEC-Mannheim Executive MBA.


Eric P. Berlin's Profile

Eric P. Berlin Related Seminars and Products

Partner

Dentons


Eric Berlin leads the US and global Cannabis teams at Dentons, the world’s largest law firm. Widely recognized as one of the nation’s leading authorities on cannabis and hemp law, Eric dedicates 100 percent of his work to clients involved in, or impacted by, the legal cannabis or hemp industries. He has worked on some of the industry’s biggest deals and counsels several of the top companies in the cannabis ecosystem. Eric’s own involvement in this area goes back more than a decade, when he worked pro bono with legislators and other interested parties to help draft and pass legislation creating medical cannabis programs in Illinois and Ohio.

Eric has represented large, publicly traded companies that sell products or services to the cannabis industry, companies involved in financing the industry, vaporizer manufacturers, testing labs, cultivators and processors, and dispensary operators.

Additionally, Eric has also represented non-cannabis industry clients in high-profile health care and antitrust litigations. Some of his successes include a trial in a $2.3 billion Sherman Act and Robinson-Patman Act case; a False Claims Act case against major pharmacies; a bundling antitrust case against a large medical distributor; an international arbitration between agricultural companies; and appeals in the US Courts of Appeals for the Sixth, Seventh, Ninth and Tenth Circuits.

His groundbreaking efforts for businesses and industry organizations have been well recognized. Eric is ranked in Tier 1 for Cannabis Law by Chambers USA, earned “MVP of the Year in Cannabis Law” by Law360 in 2020-2023, and was named a “Leading Lawyer in Cannabis” by The Legal 500 US in 2021-2024.


Sherri Altshuler's Profile

Sherri Altshuler Related Seminars and Products

Partner

Aird & Berlis LLP


Sherri earns the trust of her clients by adeptly managing complex and time-sensitive corporate finance transactions and by providing relevant, business-focused solutions to corporate/commercial and capital markets issues. Her depth of perspective and understanding of corporate and securities law matters comes from her ongoing representation of clients ranging from small and medium enterprises to established multi-billion dollar corporations. Sherri effectively prioritizes issues on complex and time-sensitive transactions, and works diligently to ensure that outcomes align with her clients’ overall business goals.

Sherri is co-Practice Group Leader of the firm's Capital Markets Group, co-Chair of the Cannabis Group and Life Sciences Group and a member of the Corporate/Commercial, Mining, Capital Pool Company and Startups Groups. Her practice is focused on mergers, acquisitions, corporate reorganizations, public and private financings and ongoing corporate and commercial matters. She has developed specialized expertise in capital markets transactions in the REIT, cannabis, technology, psychedelics and mining sectors, including with respect to board governance, securities and financing matters.

Sherri regularly advises corporations on public offerings, private placement financings, flow-through financings, reverse takeovers, stock exchange listings, continuous disclosure, corporate governance and the formation and completion of qualifying transactions for companies established under the TSX Venture Exchange Capital Pool Company Program.

Sherri is a member of the TSX Venture Exchange Ontario Advisory Committee and a former member of the Ontario Securities Commission Small and Medium Enterprises Committee. Sherri previously completed a six-month term of secondment with the Corporate Finance Branch of the Ontario Securities Commission where she was responsible for reviewing and clearing prospectuses and considering applications for relief from the requirements of the Securities Act (Ontario). Sherri also instructs Corporate Finance at Windsor Law School and is a frequent public speaker. Additionally, Sherri is called upon by the media to comment on the legal, regulatory and investment issues surrounding psychedelics in Canada.

Sherri is recognized by The Canadian Legal Lexpert Directory as a leading lawyer in the area of Corporate Finance & Securities, after previously being named one of Lexpert magazine’s Rising Stars: Canada’s Leading Lawyers under 40. Sherri is also recognized as a leading lawyer in Cannabis Law by Chambers Canada and The Best Lawyers in Canada.


Paul-Michael Keichel's Profile

Paul-Michael Keichel Related Seminars and Products

Attorney

Cullinan & Associates


Paul-Michael (“PM”) has been admitted as an Attorney of the High Court of South Africa, with right of appearance, since 2013, when he accepted the brief of the now-famous ‘Dagga Couple’ to assist them in decriminalising cannabis use, possession and trade in the country. Apart from this landmark human rights work, he continued to practice as a general and commercial litigator for a large law firm in Johannesburg, often appearing in Court himself, until his departure to pursue other opportunities and lifestyles in October of 2021. In his former role, he contributed to many matters that resulted in reported judgments in favour of his clients.

With its genesis in a cannabis assignment, written to complete his law degree in 2009, his dedicated cannabis and entheogen practice and advocacy afforded him the honour of appearing in the Constitutional Court in 2018 and noting its famous “privacy judgment” (which marked the effective start of meaningful drug reform in the country). P-M has since advised numerous local and international clients on wherever in the cannabis value chain that they may wish to establish themselves, made written and oral submissions to Parliament on more humane drug laws, assisted government, otherwise engaged with regulators, lectured and interviewed on the topic, been invited to steering committees, handled other cannabis-related litigation, and even presented on drug policy at the United Nations in Vienna.

Now practicing and consulting to Cullinan and Associates remotely from Kwa-Zulu Natal, he is leading a High Court (ultimately Constitutional Court) challenge to decriminalise the multiple legitimate uses of psilocybin, and is trying his hand generally at progressing Earth jurisprudence, while learning the ropes of being an environmental lawyer, in addition to his general human rights work – which he considers as entirely complimentary, given that humanity and nature are (inseparably) one and the same.


Mr. Ohad Kiperstok's Profile

Mr. Ohad Kiperstok Related Seminars and Products

Partner

Angel, Kiperstok y Asociados


He is a lawyer and founding partner of the firm, a Litigator focused on commercial, banking, civil and criminal litigation in the Accusatory Criminal System.

He is a specialist in commercial law, corporate law, protection and structuring of family assets, Private Interest Foundations, Public Limited Companies.

Education:
- Bachelor's degree in Law and Political Sciences. ISAE University.
-Active member of the National Bar Association.


Reviews